Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Editorial

  • 234 Articles
  • 0 Posts
  • ← Previous
  • 1
  • 2
  • 3
  • …
  • 23
  • 24
  • Next →
The first century of JCI and beyond
Elizabeth M. McNally
Elizabeth M. McNally
Published October 1, 2024
Citation Information: J Clin Invest. 2024;134(19):e186113. https://doi.org/10.1172/JCI186113.
View: Text | PDF

The first century of JCI and beyond

  • Text
  • PDF
Abstract

Authors

Elizabeth M. McNally

×

Conflicting interests: when whistleblowers profit from allegations of scientific misconduct
Elizabeth M. McNally
Elizabeth M. McNally
Published November 1, 2022
Citation Information: J Clin Invest. 2022;132(21):e166176. https://doi.org/10.1172/JCI166176.
View: Text | PDF

Conflicting interests: when whistleblowers profit from allegations of scientific misconduct

  • Text
  • PDF
Abstract

Authors

Elizabeth M. McNally

×

Data we can trust
Sarah Jackson, … , Kathleen L. Collins, Elizabeth M. McNally
Sarah Jackson, … , Kathleen L. Collins, Elizabeth M. McNally
Published August 1, 2022
Citation Information: J Clin Invest. 2022;132(15):e162884. https://doi.org/10.1172/JCI162884.
View: Text | PDF

Data we can trust

  • Text
  • PDF
Abstract

“On behalf of all authors of the submission, I warrant that the work is original and scientifically accurate ...” If you’ve submitted a manuscript to the Journal of Clinical Investigation or JCI Insight, this phrase should sound familiar. This statement is the very first thing that we ask authors to verify for every new submission. While this may seem like a simple formality or just another screen to click through, certifying the accuracy of information presented to the journal is essential to the publishing process and scientific integrity. Data accuracy forms the foundation of the scientific enterprise, and without it, the enterprise risks crumbling.

Authors

Sarah Jackson, Corinne L. Williams, Kathleen L. Collins, Elizabeth M. McNally

×

Make it even better
Elizabeth M. McNally
Elizabeth M. McNally
Published March 1, 2022
Citation Information: J Clin Invest. 2022;132(5):e158458. https://doi.org/10.1172/JCI158458.
View: Text | PDF

Make it even better

  • Text
  • PDF
Abstract

Authors

Elizabeth M. McNally

×

Ayekoo! — Well done!
Rexford S. Ahima
Rexford S. Ahima
Published February 1, 2022
Citation Information: J Clin Invest. 2022;132(3):e158278. https://doi.org/10.1172/JCI158278.
View: Text | PDF

Ayekoo! — Well done!

  • Text
  • PDF
Abstract

As the curtain draws on the 5-year term of the JCI editorial board at Johns Hopkins, I am filled with gratitude and would like to extend a warm ayekoo (Ghanaian salutation meaning “well done”) to our editors, staff, reviewers, and scientists for supporting the Journal. I am delighted to welcome the next JCI Editor in Chief, Elizabeth McNally — the first woman to lead the JCI since it was founded almost a century ago — and her team from Northwestern University.

Authors

Rexford S. Ahima

×

The Journal of Clinical Investigation in the time of COVID-19
Arturo Casadevall, … , Gordon F. Tomaselli, Rexford S. Ahima
Arturo Casadevall, … , Gordon F. Tomaselli, Rexford S. Ahima
Published December 15, 2021
Citation Information: J Clin Invest. 2021;131(24):e156409. https://doi.org/10.1172/JCI156409.
View: Text | PDF

The Journal of Clinical Investigation in the time of COVID-19

  • Text
  • PDF
Abstract

In this editorial, we describe the experience of the JCI editors during the COVID-19 pandemic. Our goal is to share how we operated during the pandemic, recount how the JCI contributed to the response, highlight some of the major papers we published on SARS-CoV-2 and COVID-19, and impart our insights in the hope that these are helpful to journal editors that may need to deal with similar types of crises in the future.

Authors

Arturo Casadevall, Sarah Jackson, Gregg L. Semenza, Gordon F. Tomaselli, Rexford S. Ahima

×

Changing the editorial process at JCI and JCI Insight in response to the COVID-19 pandemic
Rexford S. Ahima, … , Donna M. Martin, Pavan Reddy
Rexford S. Ahima, … , Donna M. Martin, Pavan Reddy
Published March 23, 2020
Citation Information: J Clin Invest. 2020. https://doi.org/10.1172/JCI138305.
View: Text | PDF

Changing the editorial process at JCI and JCI Insight in response to the COVID-19 pandemic

  • Text
  • PDF
Abstract

The editors of JCI and JCI Insight are revisiting our editorial processes in light of the strain that the COVID-19 pandemic places on the worldwide scientific community. Here, we discuss adjustments to our decision framework in light of restrictions placed on laboratory working conditions for many of our authors.

Authors

Rexford S. Ahima, Sarah Jackson, Arturo Casadevall, Gregg L. Semenza, Gordon Tomaselli, Kathleen L. Collins, Andrew P. Lieberman, Donna M. Martin, Pavan Reddy

×

Reducing bias: accounting for the order of co–first authors
Arturo Casadevall, … , Gordon Tomaselli, Rexford S. Ahima
Arturo Casadevall, … , Gordon Tomaselli, Rexford S. Ahima
Published April 29, 2019
Citation Information: J Clin Invest. 2019. https://doi.org/10.1172/JCI128764.
View: Text | PDF

Reducing bias: accounting for the order of co–first authors

  • Text
  • PDF
Abstract

Reflecting an increasing emphasis on collaborative science, the number of authors on published articles has markedly risen with time. With this trend, we see an increase in papers designating 2 or more co–first authors. To improve transparency in how such designations are made and reduce bias in the assignment of order, the JCI is now requiring an explanation for how the first-author position is determined when shared among contributing authors.

Authors

Arturo Casadevall, Gregg L. Semenza, Sarah Jackson, Gordon Tomaselli, Rexford S. Ahima

×

Figure errors, sloppy science, and fraud: keeping eyes on your data
Corinne L. Williams, … , Arturo Casadevall, Sarah Jackson
Corinne L. Williams, … , Arturo Casadevall, Sarah Jackson
Published March 25, 2019
Citation Information: J Clin Invest. 2019. https://doi.org/10.1172/JCI128380.
View: Text | PDF

Figure errors, sloppy science, and fraud: keeping eyes on your data

  • Text
  • PDF
Abstract

Recent reports suggest that there has been an increase in the number of retractions and corrections of published articles due to post-publication detection of problematic data. Moreover, fraudulent data and sloppy science have long-term effects on the scientific literature and subsequent projects based on false and unreproducible claims. At the JCI, we have introduced several data screening checks for manuscripts prior to acceptance in an attempt to reduce the number of post-publication corrections and retractions, with the ultimate goal of increasing confidence in the papers we publish.

Authors

Corinne L. Williams, Arturo Casadevall, Sarah Jackson

×

Free access to scientific publications: contrasting the JCI approach to Plan S
Sarah Jackson
Sarah Jackson
Published January 7, 2019
Citation Information: J Clin Invest. 2019. https://doi.org/10.1172/JCI126932.
View: Text | PDF

Free access to scientific publications: contrasting the JCI approach to Plan S

  • Text
  • PDF
Abstract

The JCI has made all of its research freely available to readers since 1996. As open access mandates from funders, such as Plan S, gain momentum, it’s worth revisiting how the JCI has created a durable publication model for free access to research and the benefits that society journals provide to the research community.

Authors

Sarah Jackson

×
  • ← Previous
  • 1
  • 2
  • 3
  • …
  • 23
  • 24
  • Next →

No posts were found with this tag.

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts